Focuses on National Cancer Database (NCDB), a database that will help physicians determine what is happening to the one billion patients diagnosed with cancer every year. Other information that can be determined through the computerized database; Background information of the NCDB; Distinctive ...
While data from the NCDB have contributed significantly to the study of colorectal cancer, the database remains underutilized with regard to its potential for furthering the understanding of colorectal cancers and improving the care of patients with these tumors....
Observed and Expected Cancer Cases by Patient’s Region, NCDB 2020 eTable 8. National Cancer Database Reporting Tools and Data Elements 1. Mallin K, Browner A, Palis B, et al. Incident cases captured in the National Cancer Database compared with those in U.S. population based...
National cancer database. Accessed May 5, 2020. https://www.facs.org/quality-programs/cancer/ncdb 28. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471-...
Parathyroid carcinoma: an update on treatment outcomes and prognostic factors from the National Cancer Data Base (NCDB). Ann Surg Oncol. 2015. doi:10.1245/s10434-015-4672-3.Asare EA, Sturgeon C, Winchester DJ, et al. Parathyroid Carcinoma: An Update on Treatment Outcomes and Prognostic ...
The National Cancer Database (NCDB) has collected lifetime survival data since 1989; however, the value of these data is poorly characterized. Our objective was to assess the value of long-term follow-up in the NCDB by evaluating data completeness and the time spent collecting these data. Met...
Previous Commission on Cancer studies have examined time trends in stage of disease and treatment patterns for melanoma. Reported herein are the most current National Cancer Data Base (NCDB) data for melanoma. Methods. Two calls for data have yielded 20, 165 melanoma cases for 1985, 1988, and...
In this retrospective analysis, the NCDB database was used to evaluate the determinants that affected access to multi-agent therapy among MM patients who were treated in commission on cancer-accredited facilities across the USA.Methods: Using the NCDB, we identified N= 171,261 patients diagnosed ...
A National Cancer Database Analysis of Demographics, Treatment Patterns and Survival Trends of Patients with Plasmablastic Lymphoma in US: Does Ethnicity Predict Enhanced Outcomes? Background: Plasmablastic lymphoma (PbL) is an exceedingly rare, aggressive non-Hodgkin lymphoma with overlapping features ...
Methods: Using the National Cancer Database (NCDB), we identified patients aged 40-89 years with Stage III-IV uterine cancer between 2004-2015 who received chemotherapy and/or radiotherapy. Race/ethnicity were classified as non-Hispanic (NH)-Black, Hispanic, and NH-White. Variables defined in ...